Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › peripheral neuropathy

Peripheral neuropathy

Subtypes of Peripheral neuropathy

Neurofibromatosis Type 1 5 Carpal Tunnel Syndrome 1 Hand-Arm Vibration Syndrome 1 Hereditary Spastic Paraplegia 1 Miller Fisher syndrome 1 Neuralgic amyotrophy 1 Parsonage-Turner syndrome 1

15 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for peripheral neuropathy

41 trials tracked for peripheral neuropathy: 11 in phase 3 or 4 and 2 with published results. The most-cited published study has 1020 citations.

41Trials tracked
11Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 11 Phase 2 12 Other / NA 18
  1. Phase 3 Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Completed · 1,020 cited
  2. Phase 3 Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy Completed · 9 cited
  3. Phase 3 Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy Completed
  4. Phase 3 Open Label Safety And Efficacy Study Of Pregabalin In Subjects With Nerve Pain Asociated With Human Immunodeficiency Virus (HIV) Neuropathy Completed
  5. Phase 3 A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia. Completed
  6. Phase 3 A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia Completed
Show 35 more trials
  1. Phase 3 Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients Completed
  2. Phase 3 Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy Completed
  3. Phase 3 A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. Completed
  4. Phase 3 A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain Completed
  5. Phase 3 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Completed
  6. Phase 2 Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy Completed
  7. Phase 2 Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Completed
  8. Phase 2 SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study Completed
  9. Phase 2 Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel Completed
  10. Phase 2 Effects of Vaporized Marijuana on Neuropathic Pain Completed
  11. Phase 2 Acupuncture for Chemo-Induced Peripheral Neuropathy Completed
  12. Phase 2 Micro-mobile Foot Compression and Diabetic Foot Completed
  13. Phase 2 MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy Completed
  14. Phase 2 Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel Completed
  15. Phase 2 Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy Completed
  16. Phase 2 Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy Completed
  17. Phase 2 Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy Completed
  18. N/A Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy Completed
  19. N/A Electrical Stimulation to Accelerate Wound Healing Completed
  20. N/A Investigating Mechanisms Underlying Spinal Cord Stimulation Efficacy Using Virtual Reality and Full Body Illusion Completed
  21. N/A OPEN Study: Pain Management Treatment Needs Interviews Completed
  22. N/A Reversing Diabetic Peripheral Neuropathy Through Exercise Completed
  23. N/A A Wearable "Balance Booster" - Stepping Closer to the Market Completed
  24. N/A Lidocaine for Diabetic Peripheral Neuropathy Completed
  25. N/A Botulinum Toxin Effects on Plantar Ulcer Recurrence Completed
  26. N/A Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer Completed
  27. N/A Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients Completed
  28. N/A Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer Completed
  29. N/A Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy Completed
  30. N/A Peak Plantar Pressures While Wearing a Carbon Fiber Off Loading Orthoses Completed
  31. N/A MC5-A Scrambler Therapy or TENS Therapy in Treating Patients With Chemotherapy-Induced Peripheral Neuropathy Completed
  32. N/A BlueWind Medical Reprieve System for the Treatment of PNP Completed
  33. N/A Effects of Light Emitting Diode Irradiation on the Conduction Parameters of the Superficial Radial Nerve Completed
  34. N/A Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy Completed
  35. N/A Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain Completed

Showing the 41 most-cited and recently-updated of 41 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
SPG4 frequency is 33.3% in Central Chinese HSP families with 7 novel SPAST variants identified
Genetics & Precision Medicine Cohort
SPG4 frequency is 33.3% in Central Chinese HSP families with 7 novel SPAST variants identified Genetic study finds SPAST variants in one-third of Chinese families with hereditary spastic paraplegia
An observational cohort study of 63 unrelated hereditary spastic paraplegia (HSP) families from Central China found SPAST variants in 33.3% …
Genetic testing found SPAST gene changes in one-third of Chinese families with hereditary spastic paraplegia, including seven new variants a…
Frontiers Apr 3, 2026
Mobile App with Contingency Management Improves Pain Outcomes in Adults with NF1
Anesthesiology & Pain Medicine RCT
Mobile App with Contingency Management Improves Pain Outcomes in Adults with NF1 Can a phone app help adults with NF1 manage their chronic pain?
A randomized trial in 108 adults with Neurofibromatosis Type 1 and chronic pain found that the iCanCope mobile app plus contingency manageme…
Adults with NF1 who used a phone app with rewards reported less pain interference and greater confidence in managing their chronic pain comp…
Apr 2, 2026
Case report describes multimodal treatment and single-cell sequencing in NF1 patient with Malignant Triton Tumor
Oncology
Case report describes multimodal treatment and single-cell sequencing in NF1 patient with Malignant Triton Tumor What happens when a rare cancer returns? One young woman's story offers a clue
A case report describes a 23-year-old woman with neurofibromatosis type 1 and Malignant Triton Tumor.
A 23-year-old woman with a rare chest tumor found disease stabilization after surgery failed, using a mix of chemotherapy, targeted therapy,…
Frontiers Apr 1, 2026